Results 191 to 200 of about 22,483 (254)

[Interpretation of the guidelines for diagnosing and treating paroxysmal nocturnal hemoglobinuria in China (2024)]. [PDF]

L Y Li, Rong Fu
openalex   +1 more source

Case Report: Coexisting cold agglutinin disease and acquired hemophilia A: a rituximab-responsive dual autoimmune disorder. [PDF]

Front Med (Lausanne)
Sun C, Yu J, Sun J, Jia X, Ma W, Feng S, Wang Y, Xu R.   +7 more
europepmc   +1 more source

Integrative miRNA-mRNA Network and Molecular Dynamics-Based Identification of Therapeutic Candidates for Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Pharmaceuticals (Basel)
Zhao P, Tang Y, Sun X, Xi Y, Zhang H, Xue J, Zhou W, Li H, Lu X.   +8 more
europepmc   +1 more source

When is ABO-incompatible plasma safe to transfuse? Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products. [PDF]

Blood Transfus
Shen C, Bengtsson J, Jöud M, Storry JR, Kjeldsen-Kragh J.   +4 more
europepmc   +1 more source

Two Cases of Crovalimab-Induced Platelet Recovery in Bone Marrow Failure-Associated Paroxysmal Nocturnal Hemoglobinuria (PNH). [PDF]

Cureus
Onaka T, Yamada Y, Imada K.
europepmc   +1 more source

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma. [PDF]

Cureus
Takahata A, Tanaka K, Toyota S.
europepmc   +1 more source

Paroxysmal Nocturnal Hemoglobinuria Associated Cutaneous Thrombosis: A Case Report. [PDF]

Indian Dermatol Online J
Sangwan P, Sharma A, Sharma A, Arava S, Mahapatra M, Ramam M.   +5 more
europepmc   +1 more source

Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency. [PDF]

Front Med (Lausanne)
Wu T, Wang X.
europepmc   +1 more source

First reported case of <i>Moraxella lacunata</i> bacteremia following pharyngitis in an adult with paroxysmal nocturnal hemoglobinemia receiving ravulizumab: A case report. [PDF]

IDCases
Osawa H, Shibutani K, Mori N.
europepmc   +1 more source